瑞典专利SE1451078A1 Body fluid drainage device

专利PDF首页>>瑞典专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
ABSTRACT A body fluid drainage system capsule (105) for releasing an oil mixture in the lumen of a body fluid drainage system, the capsule (105) comprising a capsule wall defining a space filled with an oil mixture, wherein the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt, and wherein the capsule wall is made of a water-soluble material. A body fluid drainage system (101) comprising an oil mixture arranged in the luminal space of the system. A method for inhibiting impairment of functionality and accuracy in a body fluid drainage system comprising applying an oil mixture to the inner surfaces of the body fluid drainage system. Use of an oil mixture in treatment of luminal surfaces of a body fluid drainage system. A sterile capsule and a sterile body fluid drainage system as well as a method for sterilising the capsule and the body fluid drainage system.
公开号:SE1451078A1
申请号:SE1451078
申请日:2014-09-15
公开日:2016-03-16
发明作者:Mikael Charlez；Mikael Löfgren
申请人:Observe Medical Aps；
IPC主号:

专利说明:

2 The inventors have realized, with the aid of literature studies that in in vitro system bacterial colonization generates a bio film that becomes mineralized (encrustation). In sterile urine, the development of encrustation has been shown to be dependent on urinary properties such as pH and ionic strength as well as on the biomaterial hydrophobic properties. Urine is generally free from bacteria and thus it is the chemistry of the urine in a measuring and / or collecting environment that dominates the variables. In infected urine, enzyme urease produced by adhered bacteria hydrolyses the urea to produce ammonia.
This elevates the urine pH, a condition that favors the precipitation of magnesium and calcium in the form of struvite and hydroxyapatite (HA). These minerals are two major component of encrustation. Similar problems can be found in drainage systems for other body fluids.
Said bio-film and related risk of nosocomial UTls are not visible to the human naked eye, at least not in the early stages of formation.
Sensor arrangement, signal processing, and signal interpretation methods of signals coming from a capacitive sensor system of a body fluid measurement system for measuring body fluid production of a patient wearing a body fluid drainage, e.g. a urine measurement system for measuring the urine production of a patient having a urine catheter, may all suffer from harder measuring conditions that are likely to arise over time during prolonged use of such a measuring system.
The inventors have presented the idea that surface degeneration may impair function of a capacitive measuring system and may cause a dysfunction of the siphon portion of the self-emptying chamber. They have conducted experiments around how the presence of a purpose selected oil in the measurement chamber of the siphon system prolongs operational life of the same. They have also suggested that priming of luminal surfaces of the system may be achieved by self-priming with the aid of the body fluid flowing through the system. Furthermore, they have suggested a way to sterilize the system.
The present invention is providing a device and a method for improving the above mentioned inconveniences by the step (s) of applying a low viscosity oil to the inner surfaces of a body fluid handling system, with the purpose of arriving at a body fluid handling system with sustained functional reliability and sustained measurement accuracy, in particular during prolonged use. The effect may be due to the oil influencing factors affecting bacterial growth and bio-film formation. The effect may also come from other mechanisms or from a synergetic effect not yet fully understood.
The present invention discloses a body fluid handling system of a measurement type having a capacitive sensor system working together with a self emptying measurement chamber and being provided with a capsule of a material that will disintegrate when coming into contact with body fluid, e.g. a water soluble material. The capsule is initially filled with a 10 15 20 25 30 35 3 purpose selected oil and when the capsule disintegrates the oil is transported with the aid of the body fluid flow to become applied to those surfaces of the body fluid handling system that becomes exposed to body fluid.
The invention is particularly useful in systems that use electronic methods for measuring the amount of body fluid passing through the system, for example capacitive measurement methods. lt will also provide an advantage in systems using self emptying chamber (s) to handle body fluid measurements. Tests have shown that the self emptying function of such chambers will continue to function reliably for several days, while within a system without the solution of the present invention, functionality may be compromised as soon as after 24 hours.
A body fluid measurement system according to the present invention thus comprises a well defined measurement chamber for temporarily collecting an amount of body fluid to measure. The chamber may be of a self emptying siphoning type, that is, the chamber, when it becomes full, empties itself by means of siphoning technique.
Thus, according to a first aspect of the present invention there is provided a body fluid drainage system container for releasing a surface protective fluid into a lumen of a body fluid drainage system handling a body fluid ex vivo. The container contains a surface protective fluid and the container is adapted to release the surface protective fluid when the body fluid drainage system is put into operation.
The body fluid drainage system container, where the surface protective fluid is sterile.
The body fluid drainage system container, where the surface protective fluid is sterilized by radiation sterilization.
The body fluid drainage system container, wherein the container is a capsule comprising a capsule wall made of a water-soluble material.
The body fluid drainage system container, wherein the surface protective fluid is an oil mixture comprising 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
According to a second aspect of the present invention there is provided a body fluid drainage system for handling a body fluid ex vivo. The body fluid drainage system comprises a chamber and the body fluid drainage system further comprises a container containing a surface protective fluid, wherein the container is arranged to release the surface protective fluid into the chamber.
The body fluid drainage system, where the container is disposed in the chamber. 10 15 20 25 30 35 4 The body fluid drainage system, wherein the container is a container as previously described.
The body fluid drainage system, wherein at least the chamber of the body fluid drainage system is sterile.
The body fluid drainage system, wherein at least the chamber of the body fluid drainage system is sterilized by gas sterilization.
The body fluid drainage system, where the surface protective fluid is sterilized by radiation sterilization and where an outer surface of the container and at least the chamber of the body fluid drainage system is sterilized by gas sterilization.
According to a third aspect of the present invention there is provided a method for sterilizing a body fluid drainage system for handling a body fluid ex vivo. The body fluid drainage system comprises a chamber. The method comprises the following steps: - providing a container containing a surface protective fluid to be released into the chamber of the body fluid drainage system, - subjecting the container to radiation sterilisation, - inserting the container into the chamber of the body fluid drainage system , - subjecting the chamber containing the container to gas sterilization.
The method, where the container is a container as previously described.
The method, wherein the body fluid drainage system is a body fluid drainage system as previously described.
According to a fourth aspect of the present invention there is provided a capsule for releasing an oil mixture into a lumen of a system handling a body fluid. The capsule comprising a capsule wall defining a space filled with an oil mixture. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt, and where the capsule wall is made of a water-soluble material .
The capsule, wherein the water-soluble material is selected from the group consisting of hydroxyfpropyl methylceliulose and polyvinyl alcohol (PVOH) or a: nixture thereof.
The capsule, wherein the oil mixture is selected from the group of silicone fluids.
The capsule, wherein the oil mixture is selected from the group of linear polydimethylsiloxanes. 10 15 20 25 30 35 5 The Capsule, wherein the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350.
The capsule, where the oil mixture is sterile.
The Capsule, where the oil mixture is sterilized by radiation sterilization.
According to a fifth aspect of the present invention there is provided a body fluid drainage system comprising a chamber, wherein an oil mixture is arranged in the chamber of the body fluid drainage system. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
The body fluid drainage system further comprises an electronic measurement system comprising electrodes arranged outside said chamber to measure changing capacitance values as body fluid level inside the chamber increases.
The body fluid drainage system, wherein the chamber comprises a self-emptying siphoning arrangement arranged to empty itself by means of siphoning technique.
The body fluid drainage system, where the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350.
The body fluid drainage system, wherein a capsule as previously described is arranged in the luminal space of the body fluid drainage system.
The body fluid drainage system, wherein the capsule is arranged upstream of the chamber or in an upstream portion of the chamber and is prevented from entering the chamber by a grate.
The body fluid drainage system, where the grate is made of a metal or polymer material.
The body fluid drainage system, where the material of the chamber is selected from a group consisting of polymer materials.
The body fluid drainage system, where the material of the chamber is selected from a group consisting of glass materials.
The body fluid drainage system, wherein the material of the chamber is selected from a group of materials having lipophilic properties The body fluid drainage system, wherein at least the chamber of the body fluid drainage system is sterile.
The body fluid drainage system, wherein at least the chamber of the body fluid drainage system is sterilized by gas sterilization. 10 15 20 25 30 35 6 According to a sixth aspect of the present invention there is provided a method for inhibiting impairment of functionality in a body fluid drainage system having inner surfaces coming into contact with body fluid. The method comprising the following step (s): - applying an oil mixture to the inner surfaces of the body fluid drainage system by self-priming with the aid of the body fluid.
The method comprises the step of spreading the oil mixture on top of the body fluid.
The method, wherein the oil mixture is applied to the inner surfaces of the body fluid drainage system when the level of body fluid in the body fluid drainage system increases.
The method, where the body fluid takes with it the oil mixture when the level of body fluid in the body fluid drainage system increases during filling of the system and thereby the oil mixture is brought in contact with and adheres to the inner surfaces.
The method, wherein the oil mixture comprises 90-100 ° /> of an oil selected from a group consisting of silicone fluids, and mineral oils, or from a mixture thereof.
The method, wherein the oil has a viscosity of at most 600 cSt, such as in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as of about 350 cSt.
The method, wherein the oil mixture is applied by connecting a patients drainage with the body fluid drainage system as previously described provided with the capsule as previously described.
According to a seventh aspect of the present invention there is provided a use of an oil mixture in treatment of luminal surfaces of a body fluid drainage system. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
The use, where the viscosity is in the interval of 200 to 600 cSt, such as 300 to 400 cSt, such as 345 to 355 cSt, such as about 350.
The use, where the oil mixture is void of antimicrobial agent.
Brief Description of the Drawings The invention will now be further explained with the aid of one or more embodiments of the invention in conjunction with the accompanying drawings of which: Figure 1a is a front view of a measurement chamber of a body fluid handling system.
Figure 1b is view of the measurement chamber of figure 1a where a front wall is removed exposing the inner structure including capsule / oil pill arrangement and grate arrangement. 10 15 20 25 30 Detailed description Definitions ln the context of the present invention the following terms and phrases will be used having the following meanings: A "body fluid handling system" denotes a system for handling of body fluid emanating from a human patient involved in a care situation, including but not limited to, a nursing situation and a treatment situation.
A “body fluid measurement system” denotes a system designed to measure the amount of body fluid emanating from a human patient involved in a care situation, including but not limited to, a nursing situation and a treatment situation.
The term "si | icone f | uid" is intended to include silicone oils such as silicone esters or other liquid silicone compounds with the general formula: .R * i ii sim-o msasss sy; where each R can be an aliphatic group such as an alkyl group, for example a methyl, ethyl or propyl radical or alkoxy group or a phenyl group, or combinations thereof; and where x has a value of from about 0 to about 10,000, preferably from about 1 to about 200, and most preferably from about 10 to about 125.
The term “body fluid” is intended to include all kinds of bodily fluids, i.e. biofluids originating from inside a body of a living person. Examples of body fluids are: urine, blood, pus, lymph, abdominal fluid, spinal fluid, cerebral I spinal fluid and ascites.
The problem Body fluids such as urine may be very aggressive on manmade surfaces, in particular on surfaces inside a body fluid drainage system, such as a body fluid measurement system. The body fluid drainage system according to the invention may be a closed system that comprises a tubing system connected to a patients drainage, e.g. a catheter, a chamber, such as a measurement chamber, intermediate chamber or analyze chamber, and a collection bag. The body fluid drainage system is located outside the body of a patient, i.e. ex vivo. The tubing system leads the body fluid from the patient to the chamber, such as a measurement chamber where a capacitive, contact-less sensor system senses the signals through the wall of the measurement chamber, and thereof calculates the volume. The chamber wall is preferably of a rigid polymeric material, easily obtained in medical equipment grades. The body fluid is preferably collected in a collection bag after it 10 15 20 25 30 35 8 has been measured or analyzed. Such a collection bag is preferably made of a flexible polymeric material, and has a volume considerably larger than the volume of the chamber.
The chamber is preferably devised to self-empty at a certain volume around 15- 20ml. The challenge in said self-emptying chamber is to handle the effects of degenerative process compromising the electric and physical properties of the delicate surfaces of the chamber caused by the body fluid over time.
Thus, and as also mentioned above, the inventor has realized, and also experienced, that within an unforeseeable amount of time there is a decrease of signal through the chamber wall that seems to be caused by a bio film formation on the surface (s) corresponding to where the sensors are arranged. There seems to be a considerable risk of a degeneration of the delicate surfaces within the region of the self-emptying system which may lead to a dysfunction of the self-emptying mechanism.
One solution to the problem would be to replace the chamber when signs of dysfunction are noticeable. However, it would be an advantage if this could be avoided, since it requires more resources.
The solution Now turning to figures 1a and 1b, the present invention teaches to apply a substance to the surfaces of the body fluid drainage system to improve sustained functionality and accuracy, such as measurement functionality and accuracy. lf a body fluid drainage system provided with a chamber 101 comprising a siphoning self-emptying arrangement begins to execute premature emptying sequences, it is likely that surface (s) of the chamber 101 critical to initiation of the self-emptying sequence, has become compromised . The solution involves arranging an oil releasing device 105 early in the flow path of the body fluid measurement system, and to let said oil releasing device 105 release oil into the system for adhering to the luminal surfaces of the system. Subsequent to release, the body fluid aids in dispersing the oil, the body fluid being an aqueous, oil repellant fluid.
The oil gets on top of the body fluid, and during a filling phase of the chamber, takes with it the oil, which oil adheres to the luminal surfaces in need thereof.
The oil is an example of a surface protective fluid. The surface protective fluid is a fluid that adheres to the inner surface of the chamber and prevents other fluids from coming into contact with the surface. When the surface protective fluid is an oil, aqueous fluids and oil repellent fluids are repelled from the surface. lt is realized by the skilled reader that this measure of providing an oil releasing device would improve not only a body fluid measurement system, but any body fluid drainage or handling system liable or susceptible to degradation over time. 10 15 20 25 30 35 9 The present invention relates to a method for improving sustained functionality and measurement accuracy in a body fluid drainage system having inner surfaces coming into contact with body fluid, the method comprising the following step (s): - applying an oil mixture to the inner surfaces of the body fluid drainage system.
By improving sustained functionality and measurement accuracy, impairment of functionality and measurement accuracy is inhibited.
Thus, the present invention relates to a method for inhibiting impairment of functionality and accuracy in a body fluid measurement system having inner surfaces coming into contact with body fluid, the method comprising the following step (s): - applying an oil mixture to the inner surfaces of the body fluid drainage system.
The oil mixture is preferably applied to inner surfaces of the body fluid drainage system by self-priming with aid of the body fluid. The oil mixture may be applied to inner surfaces of the body fluid drainage system by self-priming with aid of the body fluid flowing through the system.
The method may comprise the step spreading the oil mixture on top of the body fluid. This step may be performed before the step applying an oil mixture to the inner surfaces of the body fluid drainage system. In one embodiment, the oil mixture is applied to the inner surfaces of the body fluid drainage system when the level of body fluid in the body fluid drainage system increases.
This may be combined with the step spreading the oil mixture on top of the body fluid. This is a way to achieve self-priming of the inner surfaces with the oil mixture aided by the body fluid. In one embodiment, the body fluid takes with it the oil mixture when the level of body fluid in the drainage system increases during filling of the system and thereby the oil mixture is brought into contact with and adheres to the inner surfaces.
The body fluid may take with it the oil mixture when the level of body fluid in a chamber of the drainage system increases during filling of the chamber and thereby the oil mixture is brought in contact with and adheres to the inner surfaces.
The method may comprise the step adhering the oil mixture to the inner surfaces.
This step may be performed in combination with and after the step spreading the oil mixture on top of the body fluid. This is a way to achieve self-priming of the inner surfaces with the oil mixture aided by the body fluid.
The oil mixture may be spread on top of the body fluid, brought into contact with the inner surfaces by the body fluid and adhere to the inner surfaces. Thereby, the oil mixture is applied to the inner surfaces of the body fluid drainage system by self-priming. The body fluid may take with it the oil mixture when the level of body fluid in the drainage system increases 10 15 20 25 30 35 10 during filling of the system and thereby the oil mixture is brought in contact With and adheres to the inner surfaces.
The oil mixture may be applied to the inner surfaces of the body fluid drainage system by providing a water-soluble capsule in the body fluid handling system. The water-soluble capsule may be provided in the body fluid handling system upstream of a measurement portion and a siphoning portion of a body fluid chamber of the system.
When the oil mixture has been released the oil mixture is spread on top of the body fluid, since body fluid is an aqueous and oil repellent fluid. The oil mixture forms a layer on top of the body fluid. When the amount of body fluid in the body fluid drainage system and thus the level of body fluid in the body fluid drainage system increases the oil mixture that is floating on top of the body fluid is brought in contact with the inner surfaces of the body fluid drainage system. The oil mixture adheres to the inner surfaces and is applied to the inner surfaces. Thereby, the oil mixture is applied to the inner surfaces before the body fluid reaches higher levels of the inner surfaces. Thus, the oil mixture prevents or at least makes it more difficult for the body fluid to come into direct contact with the inner surfaces of the body fluid drainage system. The oil mixture is moved by the body fluid when the level of body fluid increases and thereby the oil mixture is applied to the inner surfaces of the body fluid drainage system just before the body fluid reaches a higher level in the body fluid drainage system. Thus, the inner surfaces are freshly coated with the oil mixture when the body fluid reaches the inner surfaces. After emptying the body fluid drainage system, the oil mixture is applied again on the inner surfaces before the body fluid reaches the inner surfaces. Thus, the inner surfaces are always freshly coated with the oil mixture when body fluid reaches the inner surfaces. Thereby, an improved resistance against degeneration of the inner surfaces of the body fluid drainage system. Consequently, the functionality of the body fluid drainage system, such as the functionality of the siphoning self-emptying arrangement, is improved.
For example, the degradation of the surfaces of the siphoning self-emptying arrangement is inhibited and thus the siphoning effect is maintained. The functionality over time is improved and impairment of the functionality is inhibited. Also the measurement accuracy of the body fluid drainage system, such as the measurement accuracy of the capacitive measurement system, is improved. For example, the degradation of the surfaces of the wall of the measurement chamber through which the capacitive measurement system senses signals inhibited and thus the sensing ability is maintained. The measurement accuracy over time is improved and impairment of the measurement accuracy is inhibited.
The body fluid drainage system may comprise a body fluid measurement chamber.
The body fluid drainage system may comprise electrodes arranged outside but close to the measurement chamber. The electrodes may be arranged to measure changing capacitance values as body fluid level inside the chamber increases. The electrodes may be arranged on 10 15 20 25 30 35 11 the outside of the measurement Chamber. The electrodes may be arranged on the outer surface of the measurement chamber. The electrodes may be integrated in the measurement chamber. The electrodes may be integrated in the measurement chamber on the outside of the measurement chamber. In one embodiment, the present invention relates to a body fluid drainage system comprising a body fluid measurement chamber, wherein the body fluid measurement system comprises an electronic measurement system comprising electrodes arranged outside but close to said measurement chamber to measure changing capacitance values as body fluid level inside the chamber increases, wherein an oil mixture is arranged in the luminal space of the body fluid drainage system, where the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof , and having a viscosity of at most 600 cSt. In one embodiment, the present invention relates to a body fluid drainage system comprising a body fluid chamber, wherein the body fluid chamber comprises a self-emptying siphoning arrangement arranged to empty itself by means of siphoning technique, where an oil mixture is arranged in the luminal space of the body fluid drainage system, wherein the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt. The self-emptying siphoning arrangement may be arranged to empty itself by means of siphoning technique when a certain volume of body fluid is present in the body fluid chamber. In one embodiment, the present invention relates to a body fluid drainage system comprising a body fluid measurement chamber and an electronic measurement system comprising electrodes arranged outside but close to said measurement chamber to measure changing capacitance values as body fluid level inside the chamber increases, wherein the capsule of the present invention is arranged in the luminal space of the measurement system. In one embodiment, the present invention relates to a body fluid drainage system comprising a body fluid chamber, wherein the body fluid chamber comprises a self-emptying siphoning arrangement arranged to empty itself by means of siphoning technique, wherein the capsule of the present invention is arranged in the luminal space of the system. The self-emptying siphoning arrangement may be arranged to empty itself by means of siphoning technique when a certain volume of body fluid is present in the body fluid chamber. ln one embodiment the present invention relates to a body fluid drainage system comprising a body fluid measurement chamber, wherein the body fluid measurement system comprises an electronic measurement system comprising electrodes arranged outside but close to said measurement chamber to measure changing capacitance values as body fluid level inside the chamber increases and the body fluid measurement chamber comprises a 10 15 20 25 30 35 12 self-emptying siphoning arrangement arranged to empty itself by means of siphoning technique, wherein the capsule of the present invention is arranged in the luminal space of the drainage system.
The present invention relates in one aspect to sterilization, where the container, such as a capsule, is sterile and is sterilized by radiation sterilization. Thereby, the surface protective fluid, such as the oil mixture, contained in the container is sterile. The present invention relates in one aspect to sterilization, where the chamber of the body fluid drainage system is sterile and is sterilized by gas sterilization. Thereby, the inner luminal surface of the chamber is sterile. ln case the container, e.g. in the form a capsule, is present in the chamber also the surface of the container is sterile by the gas sterilisation. This is advantageous if the surface of the container has been contaminated during handling of the container, such as during insertion of a capsule into the chamber of the body fluid drainage system.
Capsule The oil releasing device is preferably implemented as a capsule 105 comprising a capsule wall made of a water-soluble material. The capsule encapsulates an amount of oil.
The capsule is preferably of a shape selected from the group of cylindrical, cylindrical with hemispherical ends, spherical, oval, elliptical or of a shape rounded cubic or tablet, or of any shape suitable for the purpose.
The material of the capsule wall is a water-soluble material, preferably one that disintegrates in a few minutes when exposed to body fluid flow. One preferred material of the capsule wall is polyvinyl alcohol (PVOH). Most preferred, however, the material of the capsule wall is liytiroxgfpropyi methyloeiluiose, such as for example the material of LlCAPS eapsuies from GAPSUGEL - vwvw.capsugel.com. One particular advantage of PVOi-i is a very quick reiease of the oil because of fast disintegration. One advantage of hydroxyprooyi methylceliuiose is its stability tivhioh faciiltates handling, storage and transportation. ln one embodiment, the material of the oapsuie wali ttisintegrates vvititin one hour.
Thereby, the rnateriai of the oapsuie tyail is disihtegrated twithin one hour after is itas been exposed to body fiuid. This has the advantage that the oli mixture in the oapsuie is rapidiy released and the thus the protection of the inner surfaoes of the body fluid hahdiing system is rapidiy established. The materiai of the oaosuie tivaii may disintegrate tivithin 30 minutes after exposure to body fluid, such as »within“ lö minutes, such as within ti) rninutes, such as yvitnin ahoiit 5 ntinutes. The materiai of the oaosuie wali may disintegrate within a few minutes. The material of the capsule wait may disintegrate within a few rninutes after exposure to body fiuid. The material of the capsule wail is preferably totally disintegrated tyithih the above specified time interveis. 10 15 20 25 30 35 13 ln addition to improved accuracy, such as measurement accuracy, and operational life of the chamber, the capsule allows that the oil, as an active ingredient, is inactive during shelf life and activated first in the clinical setting.
The eapsuie provides a convenient vvay of storing and handiing the oii rnixture during transport and storage of e body fiuid dreinage systern. The capsuie eiso provides a convenient tyay of activating the protection of the inner surfaces of the body fiuid drainage system in the oiinioei situation, i.e. When the body fiuiti drainage systern is to be put in operation. The oepsuie can be stored in the body fiuid drainage systern or separately up untii of the body fiuid drainage system. Since the oii mixttire notis appiied to the inner surfaces of the body fiuid drainage systern before use of the body fiuid drainage system, the protection ot the oii rnixttire provided to the inner surfaces is not dernaged or deteriorated before use ot the body fidid rneestirenieht systern. if not stored in the body fiuid drairtege system, the eepstiie is inserteri in the body tiuid drainage systern before use. vVhen the body fiuid drainage system is to put into use, the body fluid that is entering the body fiuid drainage system dissoives the tyatensoiuhie materiei of the oapsuie vtfaii reieasing the oii rnixttire. The oii rnixture is transported vvith the body tiuid into the chamber and the oii rnixttire is titereby distributed into the ohernber. The Water-soiubie materia! is preferabiy disintegrated in a few minutes tfvhen exposed to body finid in order to release the oii rnixture rapidiy and to rapidiy estabiish the appiication of the oii mixttire on the inner surfaces of the body fiuid drainage systern aideti hy the body fiuid as desoribed above. Thereby, the protection of the inner surfaces of the body fiuid drainage systern is rapidiy estebiished.
To pretfent the capsuie from interfering with body fiuitti fiovv in the chamber it is advaritageous to provide a grate 110 or simiiar arrangement to prevent early, non dissoived fregrnents of the oapstiie to oiog the iiow ot body iiuid. it is aiso ativanteges to provide such a grate to eohfihe the oepsuie during transport and pre-Lise to en upper portion of the chamber.
Titus, the grate 110 is arranged to prevent pieces of non-dissolved capsule from traveling with the body fluid flow and temporarily blocking possible valves or siphoning system. The term “chamber” may be used as a general term denoting the whole chamber comprising a first portion 115, ie, an inlet upstream portion or ”atrium”, a second portion 120 midstream which is the actual measurement portion of the chamber presenting important surfaces for the sensors. Further downstream is provided a third portion 130, 140 providing the self-emptying siphoning arrangement 130 and outlet piping 140. To be able to treat the surfaces of the second portion 120 and the third portion 130 with oil from the capsule, the capsule is provided in the first portion 115, the atrium. The grate 110 is arranged betvveen the atrium 115 and the second portion 120 of the chamber 101. ä 10 15 20 25 30 35 14 The oil is a purpose selected oil. Viscosity may be at most 600 centiStoke (cSt, mmZ / s). Viscosity is preferably in the interval of 200 to 600 centiStoke (cSt, mmZ / s). Viscosity is more preferred in the interval of 300 to 400 centiStoke (cSt, mmz / s). Viscosity is even more preferred in the interval of 345 to 355 centiStoke (cSt, mmz / s). An oil having a viscosity of at most 600 cSt or within these intervals is spread on top of body fluid and forms a layer of the oil on top of the body fluid. The oil is spread over the surface of the body fluid. An oil having such viscosities is spread on top of the body Uid, is brought in contact with the inner surfaces of the body fluid drainage system and is applied to the inner surfaces of the body fluid drainage system in the way described above. A too high viscosity will result in that oil is not spread over the surface of body fluid and thereby not is brought into contact with inner surfaces of a body fluid drainage system and nor is applied to inner surfaces of a body fluid drainage system. lnstead an oil having a too high viscosity will accumulate and form a clump.
The oil is preferably of a grade approved for medical use. lt is preferably an oil comprising as a major constituent an oil preferably selected from the group of silicone fluids or mineral oils or from a combination thereof.
The silicone oil is preferably selected from polydimethylsiloxanes, polymethylphenylsiloxanes, polydipropylsiloxanes, and polyphenylsiloxanes. More preferably the silicon oil is selected from polydimethylsiloxanes. More preferred is an oil composition selected from the group of linear polydimethylsiloxanes, such as for example SILBIONE oil 70047 V 350 from Bluestar Silicones - vvvvw.blustarsi | icones.com. Most preferred is an oil comprising 90-100% silicone oil of viscosity about 350 cSt. The oil may be free of additive, or may comprise one or more additives.
The volume of oil provided in the capsule to achieve the described has been tested and effect is achieved with a volume of 0.5 ml of oil.
The capacitive sensors are not influenced, or being influenced only negligible by the oil mixture.
Oil treatment The inventors have also generalized that the purpose selected oil disclosed above may be applied to body fluid handling system surfaces using other methods than by capsule.
Thus a specific use of the oil is made an object of the present invention; lt is disclosed the use of a compound X in the application Y, wherein the compound X is an oil mixture comprising 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt, preferably within the interval of 300 to 400 cSt, more preferred Within the interval of 300 to 400 cSt, even more preferred 345 to 355 cSt, and most preferred about 350 cSt, and wherein the application Y is the treatment of luminal surfaces of a body fluid handling system or a body 10 15 20 25 30 35 15 fluid drainage system. By the term “treatment” is here meant an activity where the oil is applied to the surface in question regardless of the method of distribution of the oil into the luminal space of the body fluid handling system. Preferred methods include pouring oil into the luminal space, spraying, painting, immersion, soaking, releasing, and distribution with the aid of an aqueous fluid. The aqueous fluid may be body fluid. ln particular is distribution involving release of the oil mixture from a capsule as described above preferred and more preferred is distribution from such a capsule where the released oil mixture is transported into the luminal space with the body fluid. ln one particular embodiment is the container a syringe and the surface protective fluid is contained in the syringe. The surface protective fluid is then manually released form the syringe to the chamber e.g. by pressing the plunger of the syringe. The surface protective fluid is preferably distributed into the chamber in connection with the start of the operation of the drainage system. The surface protective fluid is then preferably transported into the luminal space and spread over the surfaces of the luminal space with the body fluid as described above.
Regardless of the method of distribution of the oil mixture into the luminal space, the oil mixture may be applied to the luminal surfaces of the body fluid handling system by self-priming as described above. In the present invention the oil treatment as described is taught as a single step of treatment of the surfaces for increased operational time. The oil is a non-complex compound involving no other substance, like an antimicrobial agent, such as for example chlorhexidine. lt is an advantage that no other substance, like an antimicrobial agent, such as for example chlorhexidine, is needed. The oil mixture may advantageously be void of such antimicrobial substance. This is also true regarding the oil mixture when released by capsule.
Material of chamber The material of the chamber is preferably a polymer of medical equipment grade.
More preferred the material of the chamber is a polymer of medical equipment grade, where the polymer exhibits a lipophilic surface. Most preferred the material of the chamber is polypropylene. Tests have shown that lipophilic material keep the oil at the chamber surface, in contrast to a lipophobic material which will repel the oil. Thus, with a lipophobic material the oil would be washed away by the body fluid rather quickly by time.
EXAMPLES / TESTS The following table illustrates a combination of capsule material, oil, and chamber material. 10 15 20 16 EXAMPLE Capsule Oil / viscosity Chamber Prolonged material material operational time (%) EX A hydroxypropyl Silicone / 350 cSt poly- 480 to 840 methylcelltalose propylene A series of tests with a body fluid measurement system, where the body fluid is urine, having an electronic measurement system and a self-emptying siphoning arrangement have been performed. The time until surface degradation in the form of biofilm formation were determined by measuring the time until either the electronic measurement signal is unsatisfactory or disappears or until the function of the self-emptying siphoning arrangement is unsatisfactory or ceases. The material of the measurement chamber of the measurement system is polypropylene. Tests were performed with and without oil. In tests involving an oil, the oil was supplied by means of a capsule. The oil as well as the material of the capsule wall is specified in the table above. Two different samples of urine were tested and the results are presented below.
Time until surface degradation in hours Test number Urine sample With oil Without oil 1 1 479 2 1 68 3 1 68 4 1 57 5 1 74 6 2 336 7 2 70 8 2 58 For urine sample 1 the operational time until surface degradation increased from 57-74 hours without oil to 479 hours when having an oil present, which corresponds to an extended operational time of 650-840%. For urine sample 2 the operational time until surface degradation increased from 58-70 hours without oil to 336 hours when having an oil present, which corresponds to an extended operational time of 480-580%.
According to some aspects there is provided a body fluid drainage system container for releasing a surface protective fluid into a lumen of a body fluid drainage system handling 10 15 20 25 30 35 17 a body fluid ex vivo. The container contains a surface protective fluid and the container is adapted to release the surface protective fluid when the body fluid drainage system is put into operation.
The body fluid drainage system container wherein, according to some aspects, the surface protective fluid is sterile.
The body fluid drainage system container wherein, according to some aspects, the surface protective fluid is sterilized by radiation sterilization.
The body fluid drainage system container wherein, according to some aspects, the container is a capsule comprising a capsule wall made of a water-soluble material.
The body fluid drainage system container wherein, according to some aspects, the surface protective fluid is an oil mixture comprising 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
According to some aspects there is provided a body fluid drainage system for handling a body fluid ex vivo. The body fluid drainage system comprises a chamber and the body fluid drainage system further comprises a container containing a surface protective fluid, wherein the container is arranged to release the surface protective fluid into the chamber.
The body fluid drainage system wherein, according to some aspects, the container is disposed in the chamber.
The body fluid drainage system wherein, according to some aspects, the container is a container as previously described.
The body fluid drainage system wherein, according to some aspects, at least the chamber of the body fluid drainage system is sterile.
The body fluid drainage system wherein, according to some aspects, at least the chamber of the body fluid drainage system is sterilized by gas sterilization.
The body fluid drainage system wherein, according to some aspects, the surface protective fluid is sterilized by radiation sterilization and where an outer surface of the container and at least the chamber of the body fluid drainage system is sterilized by gas sterilization.
According to some aspects there is provided a method for sterilizing a body fluid drainage system for handling a body fluid ex vivo. The body fluid drainage system comprises a chamber. The method comprises the following steps: 10 15 20 25 30 35 18 - providing a container containing a surface protective fluid to be released into the chamber of the body fluid drainage system, - subjecting the container to radiation sterilisation, - inserting the container into the chamber of the body fluid drainage system, - subjecting the chamber containing the container to gas sterilisation.
The container is sterilized using radiation sterilization so that both the surface and the contents of the container are sterilized. lonizing radiation such as Beta, gamma or X-rays is used because of their ability to penetrate substances due to their short wavelength. The high intensity radiation destroys e.g. microorganisms. ln a preferred embodiment gamma or Beta radiation is used for radiation sterilization. ln an even more preferred embodiment gamma radiation is used for radiation sterilization.
The container and the chamber cannot be sterilized at the same time using the radiation sterilization because the radiation can affect the material properties of the chamber.
Radiation sterilization may negatively affect the appearance and the surface properties of the chamber. For example, the surface properties may be changed so that biofilm forms easier on the surface. In the worst case the material of the chamber may be so affected so that the chamber is weakened and cannot hold body fluid. Therefore the container and the chamber is sterilized using gas sterilization.
When inserting the container into the chamber of the body fluid drainage system the surface of the sterilized container may be contaminated during handling. Therefore the chamber is sterilized using gas sterilization when the container is present in the chamber.
That way both the inside surface of the chamber and the outside surface of the container are sterilized. Gas sterilization is a surface sterilizer and does not affect the contents of the container. Gas sterilization function by exposing the articles to be sterilized to high concentrations of reactive gases (for example alkylating agents such as ethylene oxide, and oxidizing agents such as hydrogen peroxide and ozone). In a preferred embodiment the gas sterilization is an Ethylene Oxide (EtO) sterilization.
The sterilization provides a sterile product that can be stored for a prolonged time and which gives a high surface resistance against encrustation and bio film formation.
Thereby, the accuracy and operational life time of the body fluid drainage system is increased. 10 15 20 25 30 35 19 The method wherein, according to some aspects, the container is a container as previously described.
The method wherein, according to some aspects, the body fluid drainage system is a body fluid drainage system as previously described.
According to some aspects there is provided a capsule for releasing an oil mixture in a lumen of a system handling a body fluid. The capsule comprising a capsule wall defining a space filled with an oil mixture. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt, and where the capsule wall is made of a water-soluble material .
The capsule wherein, according to some aspects, the water-soluble material is selected from the group consisting of hyclroxypropyl methylceiltilose and polyviatyl alcohol (PVOH) or a: nixture thereof.
The capsule wherein, according to some aspects, the oil mixture is selected from the group of silicone fluids.
The capsule wherein, according to some aspects, the oil mixture is selected from the group of linear polydimethylsiloxanes.
The capsule wherein, according to some aspects, the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350 .
The capsule wherein, according to some aspects, the oil mixture is sterile.
The capsule wherein, according to some aspects, the oil mixture is sterilized by radiation sterilization.
According to some aspects there is provided a body fluid drainage system comprising a chamber, wherein an oil mixture is arranged in the chamber of the body fluid drainage system. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
The body fluid drainage system further comprises, according to some aspects, an electronic measurement system comprising electrodes arranged outside said chamber to measure changing capacitance values as body fluid level inside the chamber increases.
The body fluid drainage system wherein, according to some aspects, the chamber comprises a self-emptying siphoning arrangement arranged to empty itself by means of siphoning technique. 10 15 20 25 30 35 20 The body fluid drainage system wherein, according to some aspects, the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350.
The body fluid drainage system wherein, according to some aspects, a capsule as previously described is arranged in the luminal space of the body fluid drainage system.
The body fluid drainage system wherein, according to some aspects, the capsule is arranged upstream of the chamber or in an upstream portion of the chamber and is prevented from entering the chamber by a grate.
The body fluid drainage system wherein, according to some aspects, the grate is made of a metal or polymer material.
The body fluid drainage system wherein, according to some aspects, the material of the chamber is selected from a group consisting of polymer materials.
The body fluid drainage system wherein, according to some aspects, the material of the chamber is selected from a group consisting of glass materials.
The body fluid drainage system wherein, according to some aspects, the material of the chamber is selected from a group of materials having lipophilic properties The body fluid drainage system wherein, according to some aspects, at least the chamber of the body fluid drainage system is sterile.
The body fluid drainage system wherein, according to some aspects, at least the chamber of the body fluid drainage system is sterilized by gas sterilization.
According to some aspects there is provided a method for inhibiting impairment of functionality in a body fluid drainage system having inner surfaces coming into contact with body fluid. The method comprising the following step (s): - applying an oil mixture to the inner surfaces of the body fluid drainage system by self-priming with the aid of the body fluid.
The method comprises, according to some aspects, the step spreading the oil mixture on top of the body fluid.
The method wherein, according to some aspects, the oil mixture is applied to the inner surfaces of the body fluid drainage system when the level of body fluid in the body fluid drainage system increases.
The method wherein, according to some aspects, the body fluid takes with it the oil mixture when the level of body fluid in the body fluid drainage system increases during filling of the system and thereby the oil mixture is brought in contact with and adheres to the inner su rfaces. 10 15 20 21 The method wherein, according to some aspects, the oil mixture comprises 90- 100% of an oil selected from a group consisting of silicone fluids, and mineral oils, or from a mixture thereof.
The method wherein, according to some aspects, the oil has a viscosity of at most 600 cSt, such as in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as of about 350 cSt.
The method wherein, according to some aspects, the oil mixture is applied by connecting a patients drainage with the body fluid drainage system as previously described provided with the capsule as previously described.
According to some aspects there is provided a use of an oil mixture in treatment of luminal surfaces of a body fluid drainage system. The oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
The use wherein, according to some aspects, the viscosity is in the interval of 200 to 600 cSt, such as 300 to 400 cSt, such as 345 to 355 cSt, such as about 350.
The use wherein, according to some aspects, the oil mixture is void of antimicrobial agent.

权利要求:
Claims (43)
[1] 1. A body fluid drainage system container for releasing a surface protective fluid into a lumen of a body fluid drainage system handling a body fluid ex vivo, the container containing a surface protective fluid, wherein the container is adapted to release the surface protective fluid when the body fluid drainage system is put in operation.
[2] 2. The container according to claim 1, wherein the surface protective fluid is sterile.
[3] 3. The container according to claim 1 or 2, wherein the surface protective fluid is sterilised by radiation sterilisation.
[4] 4. The container according to any one of claims 1-3, wherein the container is a capsule comprising a capsule wall made of a water-soluble material.
[5] 5. The container according to any one of claims 1-4, wherein the surface protective fluid is an oil mixture comprising 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
[6] 6. A body fluid drainage system for handling a body fluid ex vivo, wherein the body fluid drainage system comprises a chamber, wherein the body fluid drainage system further comprises a container containing a surface protective fluid, wherein the container is arranged to release the surface protective fluid into the chamber.
[7] 7. The body fluid drainage system according to claim 6, wherein the container is disposed in the chamber.
[8] 8. The body fluid drainage system according to claim 6 or 7, wherein the container is a container according to any one of claims 1-5.
[9] 9. The body fluid drainage system according to any one of claims 6-8, wherein at least the chamber of the body fluid drainage system is sterile. 23
[10] 10. The body fluid drainage system according to claim 9, wherein at least the chamber of the body fluid drainage system is sterilised by gas sterilisation.
[11] 11. The body fluid drainage system according to claims 9 and 10, wherein the surface protective fluid is sterilised by radiation sterilisation and wherein an outer surface of the container and at least the chamber of the body fluid drainage system is sterilised by gas sterilisation.
[12] 12. Method for sterilising a body fluid drainage system for handling a body fluid ex vivo, wherein the body fluid drainage system comprises a chamber, wherein the method comprises the steps -providing a container containing a surface protective fluid to be released into the chamber of the body fluid drainage system, 1. subjecting the container to radiation sterilisation, - inserting the container into the chamber of the body fluid drainage system, and 2. subjecting the chamber containing the container to gas sterilisation.
[13] 13. Method according to claim 12, wherein the container is a container according to any one of claims 1-5.
[14] 14. Method according to claim 12 or 13, wherein the body fluid drainage system is a body fluid drainage system according to any one of claims 6-11.
[15] 15. A capsule (105) for releasing an oil mixture in a lumen of a system handling a body fluid, the capsule (105) comprising a capsule wall defining a space filled with an oil mixture, wherein the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt, and wherein the capsule wall is made of a water-soluble material.
[16] 16. The capsule (105) according to claim 15, wherein the water-soluble material is selected from the group consisting of hydroxypropyl methylcellulose and polyvinyl alcohol (PV0H) or a mixture thereof.
[17] 17. The capsule (105) according to claim 15 or 16, wherein the oil mixture is selected from the group of silicone fluids. 24
[18] 18. The capsule according to claim 17, wherein the oil mixture is selected from the group of linear polydimethylsiloxanes.
[19] 19. The capsule according to any one of claims 15-18, wherein the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350.
[20] 20. The capsule according to any one of claims 15-19, wherein the oil mixture is sterile.
[21] 21. The capsule according to claim 20, wherein the oil mixture is sterilised by radiation sterilisation.
[22] 22. A body fluid drainage system (101) comprising a chamber (101), wherein an oil mixture is arranged in the chamber of the body fluid drainage system, wherein the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
[23] 23. The body fluid drainage system according to claim 22, wherein the body fluid drainage system comprises an electronic measurement system comprising electrodes arranged outside said chamber (101) to measure changing capacitance values as body fluid level inside the chamber (101) increases.
[24] 24. The body fluid drainage system according to claim 22 or 23, wherein the chamber (101) comprises a self-emptying siphoning arrangement (130) arranged to empty itself by means of siphoning technique.
[25] 25. The body fluid drainage system according to any one of claims 22-24, wherein the viscosity of the oil is in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as about 350.
[26] 26. The body fluid drainage system according to any one of claims 22-25, wherein a capsule (105) according to any of claims 15-21 is arranged in the luminal space of the body fluid drainage system.
[27] 27. The body fluid drainage system according to claim 26, wherein the capsule (105) is arranged upstream of the chamber (101) or in an upstream portion of the chamber (101) and is prevented from entering the chamber by a grate (110).
[28] 28. The body fluid drainage system according to claim 27, wherein the grate (110) is made of a metal or polymer material.
[29] 29. The body fluid drainage system according to any one of claims 22-28, wherein the material of the chamber is selected from a group consisting of polymer materials.
[30] 30. The body fluid drainage system according to any one of claims 22-28, wherein the material of the chamber is selected from a group consisting of glass materials.
[31] 31. The body fluid drainage system according to any one of claims 22-30, wherein the material of the chamber is selected from a group of materials having lipophilic properties.
[32] 32. The body fluid drainage system according to any one of claims 22-31, wherein at least the chamber of the body fluid drainage system is sterile.
[33] 33. The body fluid drainage system according to claim 32, wherein at least the chamber of the body fluid drainage system is sterilised by gas sterilisation.
[34] 34. A method for inhibiting impairment of functionality in a body fluid drainage system having inner surfaces coming into contact with body fluid, the method comprising the following step(s): - applying an oil mixture to the inner surfaces of the body fluid drainage system by self-priming with the aid of the body fluid.
[35] 35. The method according to claim 34, wherein the method comprises the step spreading the oil mixture on top of the body fluid.
[36] 36. The method according to claim 34 or 35, wherein, the oil mixture is applied to the inner surfaces of the body fluid drainage system when the level of body fluid in the body fluid drainage system increases.
[37] 37. The method according to any one of the claims 34-36, wherein the body fluid takes with it the oil mixture when the level of body fluid in the body fluid drainage system increases during filling of the system and thereby the oil mixture is brought in contact with and adheres to the inner surfaces. 26
[38] 38. The method according to any one of claims 34-37, wherein the oil mixture comprises 90-100% of an oil selected from a group consisting of silicone fluids, and mineral oils, or from a mixture thereof.
[39] 39. The method according to any one of claims 34-38, wherein the oil has a viscosity of at most 600 cSt, such as in the interval of 200 to 600 cSt, such as in the interval of 300 to 400 cSt, such as in the interval of 345 to 355 cSt, such as of about 350 cSt.
[40] 40. The method according to any one of claims 34-39, wherein the oil mixture is applied by connecting a patient's drainage with the body fluid drainage system of any of claims 22 to 33 provided with the capsule of any of claims 15 to 21.
[41] 41. Use of an oil mixture in treatment of luminal surfaces of a body fluid drainage system, wherein the oil mixture comprises 90-100% of an oil selected from the group consisting of silicone fluids and mineral oils or a mixture thereof, and having a viscosity of at most 600 cSt.
[42] 42. The use according to claim 41, wherein the viscosity is in the interval of 200 to 600 cSt, such as 300 to 400 cSt, such as 345 to 355 cSt, such as about 350.
[43] 43. The use according to claim 41 or 42, wherein the oil mixture is void of antimicrobial agent. k;SOLOO.M991. 0

类似技术:

公开号 | 公开日 | 专利标题

US10188339B2|2019-01-29|Urine measurement device and method

Khatoon et al.2018|Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention

EP1443974B1|2012-03-14|Method for producing a sterile device

Elson et al.1977|Antibiotic-loaded acrylic cement

JP5393030B2|2014-01-22|Medical device and method for manufacturing medical device

JP5209159B2|2013-06-12|Anti-infectious device and method of manufacturing the same

JP2019500141A|2019-01-10|System and method for the treatment of wounds using negative pressure and peroxypyruvic acid

EP3193947B1|2018-12-12|Body fluid drainage device and method

JP5209322B2|2013-06-12|Use of morpholino compounds for the prevention of bacterial contamination

US20080076147A1|2008-03-27|Biofilm sampling device

JP6867412B2|2021-04-28|Encapsulated absorbent and its temporal activation

WO2014076640A1|2014-05-22|Ready-to-use device and method for removing interfering factors from samples to be subjected to microbiological examination

von Woedtke et al.2003|The influence of antimicrobial treatments on the cytocompatibility of polyurethane biosensor membranes

WO2011142928A1|2011-11-17|Indwelling fecal drainage catheter and fecal collection or ostomy pouch

EP2926794A1|2015-10-07|Ready-to-use device and method for removing interfering factors from samples to be subjected to microbiological examination

Spacers2006|In Vivo and In Vitro Studies of Antibiotic

JP2002219167A|2002-08-06|Device and method for alternating immersion for treating living-body tissue material

同族专利:

公开号 | 公开日

RU2693473C2|2019-07-03|

BR112017004548A2|2017-12-05|

US20170258952A1|2017-09-14|

ES2713696T3|2019-05-23|

BR112017004548B1|2020-12-01|

RU2017112962A|2018-10-17|

RU2017112962A3|2019-03-14|

JP2017532103A|2017-11-02|

EP3193947A1|2017-07-26|

EP3193947B1|2018-12-12|

SE538635C2|2016-10-04|

WO2016041941A1|2016-03-24|

US9861715B2|2018-01-09|

TR201903122T4|2019-03-21|

JP6602853B2|2019-11-06|

CN106714847A|2017-05-24|

CN106714847B|2019-08-06|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

GB605566A|1945-06-15|1948-07-27|George Thurlow Newton|An improved holder for razor blades|

GB1093751A|1964-02-26|1967-12-06|Aquatron Corp Aust Pty Ltd|Method and apparatus for sterilizing by ultra violet radiation|

US3962519A|1968-04-26|1976-06-08|Messrs. Willy Rusch, K.G.|Rubber article or instrument and method of producing the same|

GB1323083A|1970-07-03|1973-07-11|Elliot Lab Inc|Closed urinary drainage and irrigation systems|

US3919455A|1972-10-20|1975-11-11|Hoffmann La Roche|Apparatus for the measurement of the volume and flow rate of liquids|

US4186745A|1976-07-30|1980-02-05|Kauzlarich James J|Porous catheters|

US4863445A|1984-07-30|1989-09-05|Baxter Travenol Laboratories, Inc.|Assembly for inhibiting microbial growth in collected fluid|

GB8729977D0|1987-12-23|1988-02-03|Bard Ltd|Catheter|

US5279788A|1991-01-24|1994-01-18|Eisai Co., Ltd.|Sterilizer for sealed container utilizing microwave|

US6228635B1|1995-06-07|2001-05-08|Aastrom Bioscience, Inc.|Portable cell growth cassette for use in maintaining and growing biological cells|

US5635133A|1995-08-30|1997-06-03|Glazman; Mark|Method and apparatus for killing microorganisms in a fluid medium|

US6501893B1|1998-09-02|2002-12-31|Keiji Iimura|Photocatalytic optical fibers and apparatus using the optical fibers|

US6017334A|1996-10-03|2000-01-25|Board Of Regents, The University Of Texas System|Modified surfaces resistant to bacterial colonization|

AT261738T|1999-01-19|2004-04-15|Upjohn Co|PACKING PROCEDURE FOR OXIDATION-SENSITIVE MEDICINES|

WO2001023007A1|1999-09-24|2001-04-05|Iotron Industries Canada Inc.|Electron beam sterilization of contained liquids|

US6328937B1|1999-10-26|2001-12-11|Mark Glazman|Apparatus for killing microorganisms|

EP2260942A3|2002-05-13|2011-03-09|Becton, Dickinson and Company|Protease Inhibitor Sample Collection System|

US7147625B2|2003-07-01|2006-12-12|Icet, Inc.|Leg bag accessory|

CN1905905B|2003-09-22|2011-06-08|巴克斯特国际公司|High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products|

US7655000B2|2003-09-26|2010-02-02|Tyco Healthcare Group Lp|Urology catheter|

US7238363B2|2004-04-02|2007-07-03|Baylor College Of Medicine|Modification of medical prostheses|

GB0418560D0|2004-08-19|2004-09-22|Ssl Int Plc|Lubricant delivery|

EP2086846A4|2006-11-29|2012-01-25|Future Path Medical Llc|Container for physiological fluids|

US20100094173A1|2007-03-16|2010-04-15|Denton Marshall T|Pressure control for catheter drain tubing|

US20080279733A1|2007-05-09|2008-11-13|Mark Glazman|Apparatus for air disinfection in ventilation system|

US20110208026A1|2008-12-04|2011-08-25|Goodall Eleanor V|Systems, devices, and methods including implantable devices with anti-microbial properties|

WO2010009335A1|2008-07-17|2010-01-21|Micell Technologies, Inc.|Drug delivery medical device|

US8747764B1|2009-03-27|2014-06-10|Dartmouth-Hitchcock Clinic|Inline intravenous fluid sterilizer|

SE534493C2|2009-06-23|2011-09-06|Observe Medical Aps|Device and method for measuring urine production in patients carrying urinary catheters|

US20110146680A1|2009-06-25|2011-06-23|Conway Anthony J|Silicone catheter containing chlorhexidine gluconate|

DK2301595T3|2009-09-23|2014-04-07|Dentsply Ih Ab|Translucent catheter and method for making such a catheter|

CN108992767A|2010-03-19|2018-12-14|华盛顿大学|drainage system for excess body fluid|

US20110301553A1|2010-06-04|2011-12-08|Smiths Medical Asd, Inc.|Antimicrobial lubricant|

EP3714932A1|2011-07-12|2020-09-30|ICU Medical, Inc.|Device for delivery of antimicrobial agent into a transdermal catheter|

WO2014043650A2|2012-09-17|2014-03-20|Theranova, Llc|Systems, devices and methods for urine monitoring|

SE537614C2|2013-03-15|2015-08-04|Observe Medical Aps|Improved urine measuring device and procedure|

法律状态:

优先权:

申请号 | 申请日 | 专利标题

SE1451078A|SE538635C2|2014-09-15|2014-09-15|Method for sterilising a body fluid drainage system|SE1451078A| SE538635C2|2014-09-15|2014-09-15|Method for sterilising a body fluid drainage system|

US15/509,540| US9861715B2|2014-09-15|2015-09-15|Body fluid drainage device and method|

RU2017112962A| RU2693473C2|2014-09-15|2015-09-15|Drainage device for biological fluids and method for its sterilization|

ES15763582T| ES2713696T3|2014-09-15|2015-09-15|Device and method of draining body fluids|

JP2017514466A| JP6602853B2|2014-09-15|2015-09-15|Body fluid drainage device and body fluid drainage method|

CN201580049200.9A| CN106714847B|2014-09-15|2015-09-15|Body fluid drainage device and method|

BR112017004548-6A| BR112017004548B1|2014-09-15|2015-09-15|body fluid drainage method|

EP15763582.2A| EP3193947B1|2014-09-15|2015-09-15|Body fluid drainage device and method|

TR2019/03122T| TR201903122T4|2014-09-15|2015-09-15|Body fluid drainage device and method.|

PCT/EP2015/071058| WO2016041941A1|2014-09-15|2015-09-15|Body fluid drainage device and method|

[返回顶部]